CGON
Price
$26.15
Change
-$0.17 (-0.65%)
Updated
Jul 24, 04:59 PM (EDT)
Capitalization
1.99B
14 days until earnings call
NUVL
Price
$82.06
Change
+$1.58 (+1.96%)
Updated
Jul 24, 04:59 PM (EDT)
Capitalization
5.78B
14 days until earnings call
Interact to see
Advertisement

CGON vs NUVL

Header iconCGON vs NUVL Comparison
Open Charts CGON vs NUVLBanner chart's image
CG Oncology
Price$26.15
Change-$0.17 (-0.65%)
Volume$48.15K
Capitalization1.99B
Nuvalent
Price$82.06
Change+$1.58 (+1.96%)
Volume$6.07K
Capitalization5.78B
CGON vs NUVL Comparison Chart in %
Loading...
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGON vs. NUVL commentary
Jul 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGON is a Hold and NUVL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 25, 2025
Stock price -- (CGON: $26.32 vs. NUVL: $80.48)
Brand notoriety: CGON and NUVL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGON: 135% vs. NUVL: 56%
Market capitalization -- CGON: $1.99B vs. NUVL: $5.78B
CGON [@Biotechnology] is valued at $1.99B. NUVL’s [@Biotechnology] market capitalization is $5.78B. The market cap for tickers in the [@Biotechnology] industry ranges from $309.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGON’s FA Score shows that 0 FA rating(s) are green whileNUVL’s FA Score has 0 green FA rating(s).

  • CGON’s FA Score: 0 green, 5 red.
  • NUVL’s FA Score: 0 green, 5 red.
According to our system of comparison, NUVL is a better buy in the long-term than CGON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGON’s TA Score shows that 3 TA indicator(s) are bullish while NUVL’s TA Score has 2 bullish TA indicator(s).

  • CGON’s TA Score: 3 bullish, 4 bearish.
  • NUVL’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, CGON is a better buy in the short-term than NUVL.

Price Growth

CGON (@Biotechnology) experienced а +0.92% price change this week, while NUVL (@Biotechnology) price change was -5.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.88%. For the same industry, the average monthly price growth was +18.15%, and the average quarterly price growth was +28.82%.

Reported Earning Dates

CGON is expected to report earnings on Aug 07, 2025.

NUVL is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+5.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NUVL($5.78B) has a higher market cap than CGON($1.99B). NUVL YTD gains are higher at: 2.810 vs. CGON (-8.229). CGON has higher annual earnings (EBITDA): -134.35M vs. NUVL (-322.59M). NUVL has more cash in the bank: 1.07B vs. CGON (688M). CGON has higher revenues than NUVL: CGON (662K) vs NUVL (0).
CGONNUVLCGON / NUVL
Capitalization1.99B5.78B34%
EBITDA-134.35M-322.59M42%
Gain YTD-8.2292.810-293%
P/E RatioN/AN/A-
Revenue662K0-
Total Cash688M1.07B64%
Total Debt1.04MN/A-
TECHNICAL ANALYSIS
Technical Analysis
CGONNUVL
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 8 days ago
73%
Bullish Trend 8 days ago
81%
Declines
ODDS (%)
Bearish Trend 10 days ago
85%
Bearish Trend 2 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RSDFX40.580.27
+0.67%
Columbia Dividend Opportunity Inst2
GTLSX13.810.05
+0.36%
Glenmede Long/Short Eq Ptf Instl Shrs
SICNX14.11N/A
N/A
Schwab® International Core Equity
FZAIX56.72N/A
N/A
Fidelity Advisor International Discv Z
PRVRX12.94N/A
N/A
PGIM Quant Solutions Large-Cap Val R

NUVL and

Correlation & Price change

A.I.dvisor indicates that over the last year, NUVL has been loosely correlated with CGON. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if NUVL jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUVL
1D Price
Change %
NUVL100%
-0.25%
CGON - NUVL
56%
Loosely correlated
-2.16%
CRNX - NUVL
52%
Loosely correlated
+1.67%
ABCZF - NUVL
51%
Loosely correlated
N/A
KYMR - NUVL
51%
Loosely correlated
+1.46%
NRIX - NUVL
50%
Loosely correlated
+3.38%
More